Key Record Dates
ClinicalTrials.gov Identifier: | NCT02500199 |
---|---|
Brief Title: | Phase I Study of Pyrotinib in Patients With HER2-positive Solid Tumors |
First Submitted : | July 2, 2015 |
First Submitted that Met QC Criteria : | July 14, 2015 |
First Posted : | July 16, 2015 (Estimate) |
Last Update Submitted that Met QC Criteria : | January 28, 2021 |
Last Update Posted : | February 1, 2021 |